View all cases
UPC CFI 11/2025
Jan 20, 2025·EP2196231 · System for ambulatory drug infusion comprising a filling apparatus for flexible containers
Action number: ACT 831/2025
- Case details
- StatusCase ClosedActionGenericCategoryGeneric
- Parties
- Claimants
- Roche Diabetes Care GmbHOperating co.
Representatives- Christof Augenstein-Kather Augenstein
- Katharina Brandt-Kather Augenstein
- Robert Knaps-Kather Augenstein
- Thomas Kronberger-Grünecker Patent- und Rechtsanwälte PartGmbH
Respondents- Tandem Diabetes Care, Inc.Operating co.
- Tandem Diabetes Care Europe B.V.Operating co.
Representatives- Christian Dekoninck-Taylor Wessing
- Charlotte Garnitsch-Taylor Wessing
- Wim Maas-Taylor Wessing
- Pauline Springorum-Taylor Wessing
- Alexander Rubusch-Taylor Wessing
- George Seezink-AOMB
- Division
- Paris CD
- Technology
- InstrumentsMedical technology
- Language
- English
- First decided
- Apr 29, 2025
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Paris CD | Locked |
| Judge Paolo Catallozzi | Locked |
| Judge Tatyana Zhilova | Locked |
| Judge Giorgio Checcacci | Locked |
At the UPC: Roche Group (29 cases)·Tandem Diabetes Care Group (18 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 9 other proceedings
UPC CoA 120/2025·UPC CFI 88/2024·UPC CFI 454/2023·UPC CFI 455/2023·UPC APP 3514/2024 and 4 more
1 other defendants litigating the same or a related patent
Decisions
- 2025-04-29Application For CostsPublic
Summary: The Central Division Paris issued a costs order in connection with the revocation action UPC_CFI_454/2023, requiring Tandem Diabetes to pay Roche Diabetes Care's representation and litigation costs. The Court rejected Tandem Diabetes's request to stay the costs proceedings pending the appeal against the decision on the merits.
Show the legal issues (5)
- Costs decision
- Stay of costs proceedings
- Pending appeal against merits decision
- Reimbursable representation costs ceiling
- Art. 69 UPCA
Documents
Show all 156 documents| Document title | Date | Public |
|---|---|---|
| Final order 831-25 anonymized | 2025-04-30 | Not public |
| Final order - app for a cost decision 831-25 | 2025-04-30 | Not public |
| Headnote-and-Keywords | 2025-04-29 | Not public |
| Application-For-Costs-Decision-Outcome | 2025-04-29 | Not public |
| cost decision | 2025-04-29 | Public |
| cost decision | 2025-04-29 | Not public |
| cost decision | 2025-04-29 | Public |
| cost decision | 2025-04-29 | Not public |
| Comments Cost Application | 2025-03-21 | Not public |
| Comments Cost Application | 2025-03-21 | Not public |